Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.67
-0.85-5.15%
At close: Jun 8, 5:00 PM EST
$15.37
-0.30-1.91%
After Hours: 7:55 PM EST
Forte Biosciences Inc Analyst Ratings
FBRXNASDAQ
Forte Biosciences Analyst Ratings and Price Targets | NASDAQ:FBRX | Benzinga
Forte Biosciences Inc has a consensus price target of $41.55 based on the ratings of 6 analysts. The high is $75 issued by Guggenheim on August 18, 2025. The low is $2.75 issued by Ladenburg Thalmann on April 8, 2024. The 3 most-recent analyst ratings were released by Evercore ISI Group, Chardan Capital, and Guggenheim on November 25, 2025, November 17, 2025, and August 18, 2025, respectively. With an average price target of $67 between Evercore ISI Group, Chardan Capital, and Guggenheim, there's an implied 335.91% upside for Forte Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Evercore ISI Group
Chardan Capital
Guggenheim
Brookline Capital
Ladenburg Thalmann
1calculated from analyst ratings
Analyst Ratings for Forte Biosciences
Loading calendar...
FAQ
What is the target price for Forte Biosciences (FBRX) stock?
The latest price target for Forte Biosciences (NASDAQ:FBRX) was reported by Evercore ISI Group on November 25, 2025. The analyst firm set a price target for $65.00 expecting FBRX to rise to within 12 months (a possible 322.90% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Forte Biosciences (FBRX)?
The latest analyst rating for Forte Biosciences (NASDAQ:FBRX) was provided by Evercore ISI Group, and Forte Biosciences initiated their outperform rating.
When was the last upgrade for Forte Biosciences (FBRX)?
The last upgrade for Forte Biosciences Inc happened on April 8, 2024 when Ladenburg Thalmann raised their price target to $2.75. Ladenburg Thalmann previously had a neutral for Forte Biosciences Inc.
When was the last downgrade for Forte Biosciences (FBRX)?
There is no last downgrade for Forte Biosciences.
When is the next analyst rating going to be posted or updated for Forte Biosciences (FBRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Forte Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Forte Biosciences was filed on November 25, 2025 so you should expect the next rating to be made available sometime around November 25, 2026.
Is the Analyst Rating Forte Biosciences (FBRX) correct?
While ratings are subjective and will change, the latest Forte Biosciences (FBRX) rating was a initiated with a price target of $0.00 to $65.00. The current price Forte Biosciences (FBRX) is trading at is $15.37, which is within the analyst’s predicted range.
